Discounting in cost-utility analysis of healthcare interventions: Reassessing current practice

PharmacoEconomics

Volumn 21, Issue 2, 2003, Pages 75-87

  Cohen, Brian J ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDGET; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE COST; PRIORITY JOURNAL; REVIEW;

ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ECONOMICS, PHARMACEUTICAL; HEALTH CARE SECTOR; HEALTH PRIORITIES; HEALTH SERVICES RESEARCH; HUMANS; MARKOV CHAINS; RATE SETTING AND REVIEW; RESOURCE ALLOCATION;

EID: 0037241459     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321020-00001     Document Type: Review

References (53)

1. Broome J. Trying to value a life. J Public Econ 1978; 9:91-100
2. Mishan EJ. Consistency in the valuation of life: a wild goose chase? Soc Phil Policy 1985; 2:152-67
3. Roberts MJ. Economics and the allocation of resources to improve health. In: Agich GJ, Begley CE, editors. The price of health. Dordrecht: D. Reidel, 1986:3-22
4. Kelman S. Cost-benefit analysis: an ethical critique. In: Gillroy JM, Wade M, editors. The moral dimensions of public policy choice: beyond the market paradigm. Pittsburgh: University of Pittsburgh Press, 1992: 153-64
5. Kamlet MS. The comparative benefits modeling project: a framework for cost-utility analysis of government health care programs. Washington (DC): U.S. Public Health Service, 1992
6. Daniels N. Just health care. Cambridge, UK: Cambridge University Press, 1985
7. Callahan D. Setting limits: medical goals in an aging society. New York: Touchstone, 1987
8. Churchill LR. Rationing health care in America: perceptions and principles of justice. Notre Dame: University of Notre Dame Press, 1987
9. Kamm FM. Morality, mortality, Volume I: death and whom to save from it. New York: Oxford University Press, 1993
10. Edgar A, Salek S, Shickle D, et al. The ethical QALY: ethical issues in healthcare resource allocations. Haslemere, UK: Euromed Communications, 1998
11. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
12. Raftery J. Methodological limitations of cost-effectiveness analysis in health care: implications for decision making and service provision. J Eval Clin Pract 1999; 5: 361-6
13. Metzer D, Johannesson M. Inconsistencies in the "societal perspective" on costs of the panel on cost-effectiveness in health and medicine. Med Decis Making 1999; 19: 371-7
14. Russell LB. Cost-effectiveness analysis. In: Chapman GB, Sonnenberg FA, editors. Decision making in health care: theory, psychology, and applications. Cambridge, UK: Cambridge University Press, 2000: 158-79
15. Stewart A, Schmier JK, Luce BR. A survey of standards and guidelines for cost-effectiveness analysis in health care. Am Heart J 1999; 137:S53-61
16. Ramsey S, Sullivan S. Weighing the economic evidence: guidelines for critical assessment of cost-effectiveness analysis. J Am Board Fam Pract 1999; 12: 477-85
17. Neumann PJ, Stone PW, Chapman RH, et al. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med 2000; 132: 964-72
18. Smith AF, Brown GC. Understanding cost-effectiveness: a detailed review. Br J Ophthalmol 2000; 84: 794-8
19. Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. JAMA 1996; 276:1172-7
20. Cohen BJ. Assigning values to intermediate health states for cost-utility analysis: theory and practice. Med Decis Making 1996; 16: 376-85
21. Mishan EJ. Cost-benefit analysis. 4th edition. London: Unwin Hyman, 1988
22. Eddy DM. Cost-effectiveness analysis: a conversation with my father. JAMA 1992; 267: 1669-75
23. Broome J. Counting the cost of global warming. Cambridge: White Horse, 1992
24. Weingartner HM. Mathematical programming and the analysis of capital budgeting problems. Englewood Cliffs: Prentice-Hall, 1963
25. Baumol WJ, Quandt RE. Investment and discount rates under capital rationing - a programming approach. Econ J 1965; 75: 317-29
26. Henderson PD. Investment criteria for public enterprises. In: Turvey R, editor. Public enterprise: selected readings. Harmondsworth: Penguin Books, 1968: 86-169
27. Boness AJ. Capital budgeting: the public and private sectors. New York: Praeger, 1972
28. Lind RC. A primer on the major issues relating to the discount rate for evaluating national energy options. In: Lind RC, Arrow KA, Corey GR, et al., editors. Discounting for time and risk in energy policy. Washington, D.C.: Resources for the Future, 1982: 21-94
29. Marglin SA. Public investment criteria. London: Allen & Unwin, 1967
30. Feldstein MS. The inadequacy of weighted discount rates. In: Layard R. editor. Cost benefit analysis: selected readings. 1st ed. Harmondsworth: Penguin Education, 1974: 311-32
31. Bradford DF. Constraints on government investment opportunnities and the choice of discount rate. Am Econ Rev 1975; 65: 887-99
32. Ray A. Cost-benefit analysis: issues and methodologies. Baltimore: Johns Hopkins University Press, 1994
33. Nas TF. Cost-benefit analysis: theory and application. Thousand Oaks: Sage Publications, 1996
34. Lesser JA, Zerbe RO. Discounting procedures for environmental (and other) projects: a comment on Kolb and Scheraga. J Policy Anal Manage 1994; 13: 140-56
35. Lind RC. Reassessing the government's discount rate policy in light of new theory and data in a world economy with a high degree of capital mobility. J Environ Econ Manage 1990; 18: S8-S28
36. Prest AR, Turvey R. Cost-benefit analysis: a survey. Econ J 1965; 75: 683-735
37. Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions. Med Care 1993; 31: 403-18
38. Ganiats TG. Discounting in cost-effectiveness research. Med Decis Making 1994; 14: 298-300
39. Keeler EB, Cretin S. Discounting of life saving and other non-monetary effects. Manage Sci 1983; 29: 300-6
40. Broome J. Weighing goods. Oxford: Basil Blackwell, 1991
41. Fisher I. The theory of interest. New York: Macmillan, 1930
42. Mankiw NG. Principles of economics. 2nd ed. Fort Worth: Harcourt College Publishers, 2001
43. Conard JW. An introduction to the theory of interest. Berkeley: University of California Press, 1959
44. Keynes JM. The general theory of employment, interest, and money. London: Macmillan, 1936
45. Arrow KJ, Kurz M. Public investment, the rate of return, and optimal fiscal policy. Baltimore: Johns Hopkins University Press, 1970
46. President of the United States. Economic report of the President. Washington: United States Government Printing Office, 1999
47. Sloan FA. Introduction. In: Sloan FA, editor. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. Cambridge: Cambridge University Press, 1996: 1-14
48. Viscusi WK. Discounting health effects for medical decisions. In: Sloan FA, editor. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. Cambridge: Cambridge University Press, 1996: 125-47
49. Gafni A, Torrance GW. Risk attitude and time preference in health. Manage Sci 1984; 30: 440-51
50. Moore MJ, Viscusi WK. Models for estimating discount rates for long-term risks using labor market data. J Risk Uncertainty 1990; 3: 381-401
51. Horowitz JK, Carson RT. Discounting statistical lives. J Risk Uncertainty 1990; 3: 403-13
52. Berger ML. The once and future applications of cost-effectiveness analysis. Joint Commission J Qual Improve 1999; 25: 455-61
53. Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York: Oxford University Press, 1993